WIPO Domain Name Decision D2019-1031 for questdiagnosticinc.com
WIPO Arbitration and Mediation Center ADMINISTRATIVE PANEL DECISION Quest Diagnostics Investments LLC v. Domain Admin/Privacy Protect, LLC (PrivacyP) / John Snow Case No. D2019-1031 1. The Parties
Complainant is Quest Diagnostics Investments LLC, United States of America (“Complainant), represented by CSC Digital Brand Services AB, Sweden.
Respondent is Domain Admin/Privacy Protect, LLC (PrivacyP), United States of America / John Snow, United States of America (hereinafter, jointly and severally, “Respondent”). 2. The Domain Name and Registrar
The disputed domain name is registered with PDR Ltd. d/b/a PublicDomainR (the “Registrar”). 3. Procedural History
The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on May 6, 2019. On May 6, 2019, the Center transmitted by email to the Registrar a request for registrar verification in connection with the disputed domain name. On May 7, 2019, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the disputed domain name, which differed from the named Respondent and contact information in the Complaint. The Center sent an email communication to Complainant on May 7, 2019 providing the registrant and contact information disclosed by the Registrar, and inviting Complainant to submit an amendment to the Complaint. Complainant filed an amended Complaint on May 13, 2019.
The Center verified that the Complaint together with the amended Complaint (hereinafter, “Complaint”) satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).
In accordance with the Rules, paragraphs 2 and 4, the Center formally notified Respondent of the Complaint, and the proceedings commenced on May 13, 2019. In accordance with the Rules, paragraph 5, the due date for Response was June 2, 2019. Respondent did not submit any response. Accordingly, the Center notified Respondent’s default on June 5, 2019.
The Center appointed M. Scott Donahey as the sole panelist in this matter on June 7, 2019. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7. 4. Factual Background
Complainant is the provider of diagnostic information services regarding routine medical, drugs of abuse, and non-hospital anatomic pathology testing services. (Complaint, Annexes 6.1 and 6.2). Complainant’s stock is traded on the New York Stock Exchange. Complainant is headquartered in the United States and has facilities there and in other countries, with more than 46,000 employees, with revenues in 2018 of approximately 75 Billion United States Dollars. (Complaint, Annexes 6.3 and 6.4). Complainant has been recogniz